Latest Regulatory Change News

KALiNA Power has strengthened its financial position by selling a 180 MW load allocation for C$18 million, while advancing its Alberta gas-fired power projects amid evolving regulatory frameworks.

Platformo Ltd’s Biztrak software arm returned to positive cash flow and profitability in Q4 2025, driven by strategic cost control and digital expansion despite regulatory headwinds in Malaysia.

Betr Entertainment Limited reported a robust 25% headline turnover growth in Q2 FY26 despite a $13.2 million EBITDA loss in H1 due to customer-friendly racing outcomes and strategic investments. The company targets a positive EBITDA turnaround in H2 FY26 and FY27, supported by organic growth, Sky Racing integration, and a new share buyback program.

CAQ Holdings reported an 8% drop in leasing revenue for the December 2025 quarter amid persistently high vacancy rates, yet anticipates improved rental income following new tenancy negotiations on Hainan Island.

EDU Holdings Limited anticipates FY25 financial results near the top of its guidance, driven by strong revenue and profit growth from its higher education arm, Ikon Institute.

Generation Development Group (ASX, GDG) has reported a robust December quarter, with Funds Under Management surging across its core divisions, driven by strategic partnerships and acquisitions.

Australian Dairy Nutritionals reported a 152% surge in nutritional powder sales despite regulatory hurdles in Vietnam, while expanding its Future brand footprint across China.

Ragnar Metals has confirmed high-grade uranium mineralisation at surface over a 150m strike at its Klockartorpet Project in Sweden, revealing a 1km long uranium anomaly and multiple untested targets. The findings set the stage for further exploration and drilling plans.

Elsight has transitioned from development to production with its new Aura communications platform, delivering initial units to a leading defence contractor and expanding its U.S. presence amid a strong financial turnaround in 2025.

Arena REIT reports a $61 million uplift in portfolio valuation for H1 FY2026, driven by strong investor interest in early learning centres and a tightening yield environment. The company reaffirms its FY2026 distribution guidance, signaling confidence in its growth trajectory.

Avecho Biotechnology is close to completing recruitment for the interim analysis cohort of its pivotal Phase III trial testing a CBD capsule for insomnia, with results expected in the first half of 2026.

Tamawood Limited anticipates a substantial 40% to 50% increase in first-half FY26 profit before tax, driven by a 36.5% rise in sales and improved Work In Progress reporting confirmed by auditors.